Pathway Capital Management, LP

SEC CIK: 0001037353
Latest filing: Aug 3, 2026

SEC filings (opens in a new tab)

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Pathway Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overview All 13F holders of DNLI Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2021

Holdings of DNLI by Pathway Capital Management, LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−69,450−100.0%	Sold out	Holders
Q4 2023	69,450	$1.49M	1.7%	+69,450	New	Holders
Q4 2021	0	$0	0.0%	−1,012,240−100.0%	Sold out	Holders
Q3 2021	1,012,240	$51.1M	24.5%	+1,012,240	New	Holders